Plasma Therapy Not Effective, Likely to Be Dropped from Clinical Management Guidelines on Covid-19

Plasma Therapy could be dropped from clinical management protocol as ICMR’s expert panel found that the therapy wasn’t beneficial in reducing the progression to severe disease or death of COVID-19 patients, sources told CNN-News18. The members observed that the information and evidence on convalescent plasma​ was not found to be supportive.

The Indian Council of Medical Research is expected to issue an advisory on the same in the next few days.

India’s national task force on COVID-19 management met on Friday, May 14, to review the convalescent plasma therapy for patients infected by the Sars-Cov-2 virus. Top experts looked into the evidence profile and examined it.